814 related articles for article (PubMed ID: 29084979)
1. Exosomal microRNA signatures in multiple sclerosis reflect disease status.
Ebrahimkhani S; Vafaee F; Young PE; Hur SSJ; Hawke S; Devenney E; Beadnall H; Barnett MH; Suter CM; Buckland ME
Sci Rep; 2017 Oct; 7(1):14293. PubMed ID: 29084979
[TBL] [Abstract][Full Text] [Related]
2. Analysis of potential microRNA biomarkers for multiple sclerosis.
Al-Temaimi R; Alshammari N; Alroughani R
Exp Mol Pathol; 2024 Jun; 137():104903. PubMed ID: 38772208
[TBL] [Abstract][Full Text] [Related]
3. Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs.
Liu H; Li PW; Yang WQ; Mi H; Pan JL; Huang YC; Hou ZK; Hou QK; Luo Q; Liu FB
BMC Cancer; 2019 Feb; 19(1):129. PubMed ID: 30736753
[TBL] [Abstract][Full Text] [Related]
4. Global exosome transcriptome profiling reveals biomarkers for multiple sclerosis.
Selmaj I; Cichalewska M; Namiecinska M; Galazka G; Horzelski W; Selmaj KW; Mycko MP
Ann Neurol; 2017 May; 81(5):703-717. PubMed ID: 28411393
[TBL] [Abstract][Full Text] [Related]
5. Multiplex Analysis of Cerebrospinal Fluid and Serum Exosomes MicroRNAs of Untreated Relapsing Remitting Multiple Sclerosis (RRMS) and Proposing Noninvasive Diagnostic Biomarkers.
Mohammadinasr M; Montazersaheb S; Molavi O; Kahroba H; Talebi M; Ayromlou H; Hejazi MS
Neuromolecular Med; 2023 Sep; 25(3):402-414. PubMed ID: 37020076
[TBL] [Abstract][Full Text] [Related]
6. miR-132-3p, miR-106b-5p, and miR-19b-3p Are Associated with Brain-Derived Neurotrophic Factor Production and Clinical Activity in Multiple Sclerosis: A Pilot Study.
Sağır F; Ersoy Tunalı N; Tombul T; Koral G; Çırak S; Yılmaz V; Türkoğlu R; Tüzün E
Genet Test Mol Biomarkers; 2021 Nov; 25(11):720-726. PubMed ID: 34788141
[No Abstract] [Full Text] [Related]
7. Erythrocyte microRNA sequencing reveals differential expression in relapsing-remitting multiple sclerosis.
Groen K; Maltby VE; Lea RA; Sanders KA; Fink JL; Scott RJ; Tajouri L; Lechner-Scott J
BMC Med Genomics; 2018 May; 11(1):48. PubMed ID: 29783973
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Tumor-Derived Exosomal miRNA as Potential Diagnostic Biomarkers for Early-Stage Non-Small Cell Lung Cancer Using Next-Generation Sequencing.
Jin X; Chen Y; Chen H; Fei S; Chen D; Cai X; Liu L; Lin B; Su H; Zhao L; Su M; Pan H; Shen L; Xie D; Xie C
Clin Cancer Res; 2017 Sep; 23(17):5311-5319. PubMed ID: 28606918
[No Abstract] [Full Text] [Related]
9. Exosomal onco-miRs from serum of patients with adenocarcinoma of the esophagus: comparison of miRNA profiles of exosomes and matching tumor.
Warnecke-Eberz U; Chon SH; Hölscher AH; Drebber U; Bollschweiler E
Tumour Biol; 2015 Jun; 36(6):4643-53. PubMed ID: 25631748
[TBL] [Abstract][Full Text] [Related]
10. Plasma Exosomal miRNAs in Persons with and without Alzheimer Disease: Altered Expression and Prospects for Biomarkers.
Lugli G; Cohen AM; Bennett DA; Shah RC; Fields CJ; Hernandez AG; Smalheiser NR
PLoS One; 2015; 10(10):e0139233. PubMed ID: 26426747
[TBL] [Abstract][Full Text] [Related]
11. Decreased circulating miRNA levels in patients with primary progressive multiple sclerosis.
Fenoglio C; Ridolfi E; Cantoni C; De Riz M; Bonsi R; Serpente M; Villa C; Pietroboni AM; Naismith RT; Alvarez E; Parks BJ; Bresolin N; Cross AH; Piccio LM; Galimberti D; Scarpini E
Mult Scler; 2013 Dec; 19(14):1938-42. PubMed ID: 24277735
[TBL] [Abstract][Full Text] [Related]
12. Circulating Exosomal miRNAs as Novel Biomarkers for Stable Coronary Artery Disease.
Zhang P; Liang T; Chen Y; Wang X; Wu T; Xie Z; Luo J; Yu Y; Yu H
Biomed Res Int; 2020; 2020():3593962. PubMed ID: 33381550
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis of microRNA profiles in multiple sclerosis including next-generation sequencing.
Keller A; Leidinger P; Steinmeyer F; Stähler C; Franke A; Hemmrich-Stanisak G; Kappel A; Wright I; Dörr J; Paul F; Diem R; Tocariu-Krick B; Meder B; Backes C; Meese E; Ruprecht K
Mult Scler; 2014 Mar; 20(3):295-303. PubMed ID: 23836875
[TBL] [Abstract][Full Text] [Related]
14. The exosome encapsulated microRNAs as circulating diagnostic marker for hepatocellular carcinoma with low alpha-fetoprotein.
Ghosh S; Bhowmik S; Majumdar S; Goswami A; Chakraborty J; Gupta S; Aggarwal S; Ray S; Chatterjee R; Bhattacharyya S; Dutta M; Datta S; Chowdhury A; Dhali GK; Banerjee S
Int J Cancer; 2020 Nov; 147(10):2934-2947. PubMed ID: 32441313
[TBL] [Abstract][Full Text] [Related]
15. Circulating microRNAs as biomarkers in progressive multiple sclerosis.
Vistbakka J; Elovaara I; Lehtimäki T; Hagman S
Mult Scler; 2017 Mar; 23(3):403-412. PubMed ID: 27246141
[TBL] [Abstract][Full Text] [Related]
16. Proteomic analysis and microRNA expression profiling of plasma-derived exosomes in primary immune thrombocytopenia.
Sun Y; Hou Y; Meng G; Han P; Zhao Y; Wang H; Xu M; Wang Y; Qiu J; Peng J; Shao L; Sun L; Hou M
Br J Haematol; 2021 Sep; 194(6):1045-1052. PubMed ID: 34337736
[TBL] [Abstract][Full Text] [Related]
17. Dependence of intracellular and exosomal microRNAs on viral E6/E7 oncogene expression in HPV-positive tumor cells.
Honegger A; Schilling D; Bastian S; Sponagel J; Kuryshev V; Sültmann H; Scheffner M; Hoppe-Seyler K; Hoppe-Seyler F
PLoS Pathog; 2015 Mar; 11(3):e1004712. PubMed ID: 25760330
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of exosomal microRNAs in fresh and senescent apheresis platelet concentrates.
Mi Z; Gong L; Kong Y; Zhao P; Yin Y; Xu H; Tian L; Liu Z
Platelets; 2022 Nov; 33(8):1260-1269. PubMed ID: 35968647
[TBL] [Abstract][Full Text] [Related]
19. A serum exosomal microRNA panel as a potential biomarker test for gastric cancer.
Wang N; Wang L; Yang Y; Gong L; Xiao B; Liu X
Biochem Biophys Res Commun; 2017 Nov; 493(3):1322-1328. PubMed ID: 28986250
[TBL] [Abstract][Full Text] [Related]
20. Exosomal small RNA sequencing uncovers the microRNA dose markers for power frequency electromagnetic field exposure.
Li H; Lin L; Li L; Zhou L; Zhang Y; Hao S; Ding Z
Biomarkers; 2018; 23(4):315-327. PubMed ID: 29297241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
